Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Total Liabilities: 2019-2024

Historic Total Liabilities for Pharming Group N.V (PHAR) over the last 4 years, with Dec 2024 value amounting to $178.9 million.

  • Pharming Group N.V's Total Liabilities rose 11.34% to $473.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 1.30%. This contributed to the annual value of $178.9 million for FY2024, which is N/A change from last year.
  • Pharming Group N.V's Total Liabilities amounted to $178.9 million in FY2024, which was up 108,338.79% from $165,000 recorded in FY2021.
  • Pharming Group N.V's 5-year Total Liabilities high stood at $178.9 million for FY2024, and its period low was $165,000 during FY2021.
  • Over the past 1 years, Pharming Group N.V's median Total Liabilities value was $178.9 million (recorded in 2024), while the average stood at $178.9 million.
  • Data for Pharming Group N.V's Total Liabilities shows a maximum YoY slumped of 99.85% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Pharming Group N.V's Total Liabilities stood at $392,000 in 2020, then crashed by 57.91% to $165,000 in 2021, then reached $178.9 million in 2024.